Latest News & Updates
Breaking News
9 minutes ago
Simantini Singh Deo
Other trending news you may like to read
FDA Supports Dewpoint Therapeutics’ DPTX3186 With Fast Track Designation For Gastric Cancer Treatment
FDA grants Fast Track status to Dewpoint’s DPTX3186, an oral condensate modulator targeting Wnt/β-catenin for gastric cancer.
Simantini Singh Deo
Onco360 Selected By Kura Oncology As Pharmacy Partner For Komzifti™ To Treat Adult AML Patients With NPM1 Mutation
Onco360 is selected by Kura Oncology as a pharmacy partner for Komzifti, a new menin inhibitor therapy for relapsed or refractory AML with NPM1 mutation.
Simantini Singh Deo
Silo Pharma Teams Up With Allucent To Support Planned FDA Investigational New Drug Filing For SPC-15 Targeting PTSD
Silo Pharma selects Allucent to prepare its IND for SPC-15, aiming to launch a Phase 1 intranasal PTSD trial in 2026.
Simantini Singh Deo
COSCIENS Biopharma Appoints Chairman Peter H. Puccetti, CFA, As Interim CEO Following Anna Biehn’s Departure
COSCIENS Biopharma appoints Peter H. Puccetti as Interim CEO amid ongoing restructuring efforts.
Simantini Singh Deo
